EssilorLuxottica Advances Med-Tech Ambitions with Addition of Belgian Ophthalmology Platform Signifeye

EssilorLuxottica Advances Med-Tech Ambitions with Addition of Belgian Ophthalmology Platform Signifeye

(IN BRIEF) EssilorLuxottica has announced plans to acquire Signifeye, a leading Belgian ophthalmology platform operating 15 clinics across the Flanders region, further expanding its presence in specialized eye care. The deal follows the recent acquisition of Optegra and supports the Group’s broader med-tech strategy to create an integrated eye care model spanning prevention, diagnosis, and advanced treatment. Signifeye’s strong reputation for clinical excellence and comprehensive service offering aligns closely with EssilorLuxottica’s ambitions to deliver end-to-end, patient-focused eye health solutions. The transaction is expected to close by Q1 2026.

(PRESS RELEASE) PARIS, 12-Dec-2025 — /EuropaWire/ — EssilorLuxottica has entered into an agreement to acquire Signifeye, a prominent ophthalmology platform based in Belgium that operates 15 eye centers and clinics across the Flanders region. The move expands EssilorLuxottica’s footprint in specialized eye care while reinforcing its long-term strategy to build an integrated, medically focused vision care ecosystem.

The acquisition follows closely on the heels of EssilorLuxottica’s recent purchase of Optegra, a rapidly expanding ophthalmology network with more than 70 clinics across the UK, Czech Republic, Poland, Slovakia, and the Netherlands. Together, these investments reflect the Group’s commitment to advancing its med-tech ambitions and developing a comprehensive care model that spans prevention, early diagnosis, and advanced clinical treatment.

Signifeye offers a broad range of ophthalmic services, covering both essential medical treatments and elective vision procedures. Much like Optegra, the platform has earned recognition in the private healthcare sector for its strong clinical standards, patient trust, and consistently high-quality outcomes. Its approach aligns closely with EssilorLuxottica’s vision of delivering expert-led, patient-centered care across the entire eye health journey.

EssilorLuxottica leadership highlighted that the integration of Signifeye will further strengthen the company’s ability to provide seamless, end-to-end eye care solutions. By combining EssilorLuxottica’s scientific and medical innovation capabilities with Signifeye’s established clinical expertise, the Group aims to elevate patient experience and redefine standards of medical excellence in ophthalmology.

From Signifeye’s perspective, the partnership is seen as a pivotal step in its evolution. By joining forces with EssilorLuxottica and Optegra, the platform expects to accelerate its mission of delivering high-quality eye care while benefiting from the scale, resources, and global reach of a leading vision care organization.

The transaction is anticipated to be finalized by the first quarter of 2026, subject to customary closing conditions.

Media Contacts:

Giorgio Iannella
Head of Investor Relations
ir@essilorluxottica.com

Marco Catalani
Head of Corporate Communications
media@essilorluxottica.com

About EssilorLuxottica
EssilorLuxottica is a global leader in the design, manufacture and distribution of advanced vision care products, eyewear and med-tech solutions. The Group is home to the most innovative lens technologies, including Varilux, Stellest and Transitions, iconic brands such as Ray-Ban, Oakley and Supreme, top-selling smart eyewear products including Ray-Ban Meta, Oakley Meta Vanguard and Nuance Audio, the most desired luxury licensed brands and world-class retailers including Sunglass Hut, LensCrafters, Vision Express and Apollo. With over
200,000 employees across 150 countries, 600 operations facilities, serving 300,000 eye care professionals and operating 18,000 stores, the Group generated consolidated revenue of Euro 26.5 billion in 2024. EssilorLuxottica
trades on the Euronext Paris market and is included in the Euro Stoxx 50 and CAC 40 indices. Codes and symbols: ISIN: FR0000121667; Reuters: ESLX.PA; Bloomberg: EL:FP. www.essilorluxottica.com

SOURCE: EssilorLuxottica